Echavez, Dionesia J.
HRN: 25-33-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/23/2024
06/30/2024
IV
1.5
Q6
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes